List view / Grid view
14 July 2019 | By Victoria Rees (European Pharmaceutical Review)
The global controlled release drug delivery market will be worth an estimated $91.2 billion by 2026, according to a new study.
8 July 2019 | By European Pharmaceutical Review
Vizimpro (dacomitinib) has been recommended as a first-line treatment option for patients with lung cancer.
3 July 2019 | By European Pharmaceutical Review
The price of over 3400 drugs have been hiked in the first half of 2019, surpassing the number of hikes imposed during the same period last year.
3 July 2019 | By Victoria Rees (European Pharmaceutical Review)
Substandard and counterfeit drugs can negatively impact the pharmaceutical industry and patients. Here, we investigate counterfeits in south-east Asia and possible solutions.
2 July 2019 | By European Pharmaceutical Review
Pharmaceutical company, Pfizer, has announced it has completed the acquisition of Therachon for $340 million.
1 July 2019 | By European Pharmaceutical Review
Former FDA Commissioner, Scott Gottlieb, who stepped down from the administration in April, has joined Pfizer’s board of directors.
28 June 2019 | By European Pharmaceutical Review
Pharmaceutical company Pfizer was able to target the distribution of counterfeit Viagra in Hong Kong through serialisation technology.
26 June 2019 | By European Pharmaceutical Review
According to Reuters, GSK has started the sale of some consumer health brands as it seeks to raise £1 billion.
21 June 2019 | By Victoria Rees (European Pharmaceutical Review)
A multi-company system to improve traceability of pharmaceutical products is newly supported by the FDA.
13 May 2019 | By Unjulie Bhanot
There are many business challenges to developing a biologics drug, one of which is effective data management. In this article, Unjulie Bhanot focuses on efficient data management policies and systems, and how they could improve biologics product development processes.
3 May 2019 | By Alice Laures - GSK, Lisa Wysocki - GSK, Paul J Newby - GSK
Modernisation of microbiological test methods involves far more than just the science. As new systems and technologies become available it becomes increasingly important that potential users can identify not only the technical requirements, but also the business case. Here, Paul Newby, Alice Laures and Lisa Wysocki from GlaxoSmithKline discuss criteria…
26 February 2019 | By European Pharmaceutical Review
The global antibiotics market is set to increase at a CAGR of 4 percent to $62.06 billion, due to the rising prevalence of infectious diseases...
20 February 2019 | By European Pharmaceutical Review
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028...
25 September 2018 | By Mike Stones
The new hub is designed to speed the response to deadly pandemics by improving the development and manufacturing of vaccines – particularly in low- and middle-income countries...
1 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A new study has found a blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests...
